Cargando…
R292K Substitution and Drug Susceptibility of Influenza A(H7N9) Viruses
Neuraminidase inhibitors are the only licensed antiviral medications available to treat avian influenza A(H7N9) virus infections in humans. According to a neuraminidase inhibition assay, an R292K substitution reduced antiviral efficacy of inhibitors, especially oseltamivir, and decreased viral fitne...
Autores principales: | Sleeman, Katrina, Guo, Zhu, Barnes, John, Shaw, Michael, Stevens, James, Gubareva, Larisa V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810934/ https://www.ncbi.nlm.nih.gov/pubmed/23965618 http://dx.doi.org/10.3201/eid1909.130724 |
Ejemplares similares
-
Human Infections with Novel Reassortant Influenza A(H3N2)v Viruses, United States, 2011
por: Lindstrom, Stephen, et al.
Publicado: (2012) -
Antiviral Drug–Resistant Influenza B Viruses Carrying H134N Substitution in Neuraminidase, Laos, February 2016
por: Baranovich, Tatiana, et al.
Publicado: (2017) -
Influenza B Viruses with Mutation in the Neuraminidase Active Site, North Carolina, USA, 2010–11
por: Sleeman, Katrina, et al.
Publicado: (2011) -
Drug susceptibility profile and pathogenicity of H7N9 influenza virus (Anhui1 lineage) with R292K substitution
por: Zhang, Xiaonan, et al.
Publicado: (2014) -
Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir
por: Mishin, Vasiliy P., et al.
Publicado: (2019)